The 2nd National ICE-T (Immune Cell Effector Therapy) Congress is a specialized clinical conference focused on the latest advancements in cellular and bispecific therapies for hematologic and solid tumors.

Scheduled for April 18, 2026, in Charlotte, North Carolina, the congress brings together oncologists, researchers, and nurses to discuss CAR-T innovations, the management of immune-related toxicities, and strategies for improving equitable access to advanced immunotherapies. The technical program includes sessions on multiple myeloma, lymphoma, and leukemia, concluding with a keynote on the future of T-cell engager therapies.

Register.